Poop pills & pills: radical combo aims to reboot cancer treatment
NCT ID NCT05533983
Summary
This study is testing whether a fecal microbiota transplant (FMT) can help patients with advanced solid cancers who have stopped responding to a common type of immunotherapy. The goal is to see if changing the gut bacteria with FMT can make the cancer respond again to the drug nivolumab. It will enroll about 50 patients who have progressed on prior immunotherapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Asan Medical Center
RECRUITINGSeoul, 05505, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.